综述

Hippo/YAP和Wnt/β-catenin通路的对话

展开
  • 1. 复旦大学分子医学教育部重点实验室, 上海 200032;
    2. 复旦大学出生缺陷研究中心, 上海 200032
许飞, 直博生, 研究方向:肿瘤信号通路。E-mail:dashing1988@163.com

收稿日期: 2013-08-26

  修回日期: 2013-11-25

  网络出版日期: 2014-01-25

基金资助

高等学校博士学科点专项科研基金(新教师类课题)(编号:20110071120033)资助

Crosstalk of Hippo/YAP and Wnt/β-catenin pathways

Expand
  • 1. Key Laboratory of Molecular Medicine, Ministry of Education, Shanghai Medical College, Fudan University, Shanghai 200032, China; 
    2. Institutes of Biomedical Sciences, Research Center for Birth Defects, Fudan University, Shanghai 200032, China

Received date: 2013-08-26

  Revised date: 2013-11-25

  Online published: 2014-01-25

摘要

Hippo/YAP通路和Wnt/β-catenin通路是在细胞的生长分化、组织器官形成以及成体干细胞的维持等方面都起着重要作用的两条信号通路。在哺乳动物细胞中, Wnt/β-catenin通路通过一系列胞质蛋白的相互作用, 使β-catenin蛋白在胞质内累积, 进而入核传递生长刺激信号。Hippo/YAP通路通过激酶级联反应磷酸化YAP/TAZ, 使其滞留在细胞质中, 抑制了YAP/TAZ的转录活性, 从而限制细胞的生长增殖, 诱导细胞凋亡。这两条通路的异常调控往往会导致肿瘤的发生。近年来越来越多的研究证实, Hippo/YAP 和Wnt/β-catenin在很多方面相互影响, 共同参与组织生长和胚胎发育的调控。研究这两个通路在肿瘤发生过程中的转导和调控以及它们相互作用的机制, 有助于为肿瘤的防治提供新的思路与策略。文章对这两条通路的协同作用及其分子机制进行了综述。

本文引用格式

许飞, 张进, 马端 . Hippo/YAP和Wnt/β-catenin通路的对话[J]. 遗传, 2014 , 36(2) : 95 -102 . DOI: 10.3724/SP.J.1005.2014.0095

Abstract

Wnt/β-catenin and Hippo/YAP pathways are known to be important for development, growth, organogenesis, and maintenance of adult stem cells. In mammalian cells, Wnt signalling stabilises cytoplasmic β-catenin through several core molecules to promote β-catenin to enter the nucleus, thus delivers the growth -promoting signal. Hippo kinase cascade pathway promotes cytoplasmic localization of YAP/TAZ, which restricts cell proliferation and induces apoptosis. Deregula-tion of these two pathways could lead to tumorigenesis. Growing data indicate that these two pathways influence each other in a number of ways to properly regulate tissue growth and repair. Elucidating the regulatory mechanism and biological functions of Hippo/YAP and Wnt/β-catenin pathways might reveal potential targets for tumor therapeutic intervention. In this review, we discuss on the interactions between Wnt/β-catenin and Hippo/YAP pathways, and how these interactions contribute to tumorigenesis.

参考文献

[1] Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer, 2013, 13(1): 11–26. <\p>

[2] Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I, Hein K, Vogt R, Kemler R. Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science, 2012, 336(6088): 1549–1554. <\p>

[3] Ouyang H, Zhuo YH, Zhang K. WNT signaling in stem cell differentiation and tumor formation. J Clin Invest, 2013, 123(4): 1422–1424. <\p>

[4] Watson AL, Rahrmann EP, Moriarity BS, Choi K, Conboy CB, Greeley AD, Halfond AL, Anderson LK, Wahl BR, Keng VW, Rizzardi AE, Forster CL, Collins MH, Sarver A, Wallace MR, Schmechel SC, Ratner N, Largaespada DA. Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. Cancer Discov, 2013, 3(6): 674–689. <\p>

[5] Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev, 2013, 27(4): 355–371. <\p>

[6] Huang J, Wu S, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell pro-liferation and apoptosis by inactivating Yorkie, the Dro-sophila Homolog of YAP. Cell, 2005, 122(3): 421–434. <\p>

[7] Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Sil-ber J, Zider A. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol, 2008, 18(6): 435–441. <\p>

[8] Kaneko KJ, DePamphilis ML. Regulation of gene expres-sion at the beginning of mammalian development and the TEAD family of transcription factors. Dev Genet, 1998, 22(1): 43–55. <\p>

[9] Sharma RP, Chopra VL. Effect of the Wingless (wg1) mu-tation on wing and haltere development in Drosophila melanogaster. Dev Biol, 1976, 48(2): 461–465. <\p>

[10] Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 1982, 31(1): 99– 109. <\p>

[11] Cabrera CV, Alonso MC, Johnston P, Phillips RG, Law-rence PA. Phenocopies induced with antisense RNA iden-tify the wingless gene. Cell, 1987, 50(4): 659–663. <\p>

[12] Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment po-larity gene wingless. Cell, 1987, 50(4): 649–657. <\p>

[13] Willert K, Brown JD, Danenberg E, Duncan AW, Weiss-man IL, Reya T, Yates JR, Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature, 2003, 423(6938): 448–452. <\p>

[14] Hsieh JC, Rattner A, Smallwood PM, Nathans J. Bio-chemical characterization of Wnt-frizzled interactions us-ing a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA, 1999, 96(7): 3546–3551. <\p>

[15] Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Na-ture, 2001, 412(6842): 86–90. <\p>

[16] Kimelman D, Xu W. beta-catenin destruction complex: in-sights and questions from a structural perspective. Onco-gene, 2006, 25(57): 7482–7491. <\p>

[17] Maher MT, Mo R, Flozak AS, Peled ON, Gottardi CJ. Beta-catenin phosphorylated at serine 45 is spatially un-coupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling. PloS ONE, 2010, 5(4): e10184. <\p>

[18] Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome path-way. EMBO J, 1997, 16(13): 3797–3804. <\p>

[19] Marikawa Y, Elinson RP. beta-TrCP is a negative regulator of the Wnt/beta-catenin signaling pathway and dorsal axis formation in X

文章导航

/